Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05253495
Title	Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma (RADICAL)
Acronym	RADICAL
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	New York Medical College
Indications	non-Hodgkin lymphoma diffuse large B-cell lymphoma B-cell lymphoma Burkitt lymphoma Hodgkin's lymphoma
Therapies	Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Hydrocortisone Sodium Succinate + Methotrexate + Rituximab + Vincristine Sulfate Cyclophosphamide + Dexamethasone + Vincristine Sulfate Cytarabine + Etoposide + Polatuzumab vedotin-piiq + Rituximab Cytarabine + Etoposide + Polatuzumab vedotin-piiq Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Hydrocortisone Sodium Succinate + Methotrexate + Polatuzumab vedotin-piiq Cyclophosphamide + Cytarabine + Dexamethasone + Doxorubicin + Hydrocortisone Sodium Succinate + Methotrexate + Polatuzumab vedotin-piiq + Rituximab Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab + Rituximab + Vinblastine Brentuximab vedotin + Nivolumab + Rituximab + Vinblastine Brentuximab vedotin + Dacarbazine + Doxorubicin + Nivolumab + Vinblastine Cytarabine + Methotrexate + Rituximab Brentuximab vedotin + Dacarbazine + Doxorubicin + Rituximab + Vinblastine Cyclophosphamide + Doxorubicin + Polatuzumab vedotin-piiq
Age Groups:	adult \| child
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
University of Alabama	NOT_YET_RECRUITING	Birmingham	Alabama	35233	United States	Details
University of Flordia	RECRUITING	Gainesville	Florida	32610	United States	Details
New York Medical College	RECRUITING	Valhalla	New York	10595	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field